Ernexa Therapeutics Inc.
(NASDAQ: ERNA)
Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.
1.320
+0.010
(+0.76%)
Range
1.201 - 1.320
(9.91%)
Open
1.210
Previous Close
1.310
Bid Price
2.230
Bid Volume
8
Ask Price
2.290
Ask Volume
14
Volume
31,636
Value
-
Remark
Delayed prices. Updated at 06 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
